Gilbert L'italien

Gil is an accomplished Health Economics and Outcomes Research (HEOR) executive with over 25 years of global and regional HEOR/Epidemiology experience in both academia and industry across a wide variety of disease areas, with emphasis in the neuroscience field. Gil has held roles of increasing responsibility previously at Bristol Myers Squibb Company, and most recently at Alexion Inc and Biogen Inc. He has deep expertise with regard to orphan disease drug development, psychometric and functional scale validation and real-world evidence generation to support regulatory and reimbursement objectives. Prior to his industry roles, Gil served as Cardiovascular Research Director at Mass General Hospital and held a faculty appointment at Harvard University.

Gil is also a committed volunteer, devoting his time and resources to helping underserved children globally and our vulnerable elderly population in the U.S. Gil earned his PhD in Epidemiology/Biostatistics from the Boston University School of Public Health and has served as Adjunct Assistant Professor at Yale University School of Medicine.